Find Grants

Search results

• Prot#PL101-HD301: Prilenia Therapeutics / A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Arm, Multicenter Study Evaluating the Efficacy and Safety of Pridopidine in Patients with Early Stage of Huntington Disease (PROOF-HD)

  Bega, D.

  HSG Clinical Research, Inc., Prilenia Neurotherapeutics Ltd

  11/24/20 → 11/24/24

  Project: Research project

• Prot #NU 19S01: A Phase II Study of Cabozantinib and Temozolomide in Patients with Unresectable or Metastatic Leiomyosarcoma and Other Soft Tissue Sarcomas

  Mulcahy, M. F.

  Exelixis Inc.

  11/25/19 → 11/25/24

  Project: Research project

• Prot #INCB18424-MA-GD-301: An Open-Label, Expanded Access Program of Ruxolitinib for the Treatment of Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplant

  Frankfurt, O.

  PAREXEL International Corporation, Incyte Corporation

  11/28/18 → 11/28/24

  Project: Research project

• Prot #MNA-3521-012: An Open Label Phase 1A/B Study Of Mtl-Cebpa In Combination With A Pd-1 Inhibitor (Pembrolizumab) In Adult Patients With Advanced Solid Tumours (TIMEPOINT)

  Mahalingam, D.

  Ergomed Clinical Research Inc., MiNA Alpha Limited

  11/29/21 → 11/29/24

  Project: Research project

• Off-campus support for Dry Rifting In the Albertine-Rhino graben (DRIAR), Uganda

  van der Lee, S.

  National Science Foundation

  12/1/20 → 11/30/24

  Project: Research project

• Equipment Subproject for Molecular mechanisms controlling kinetochore-microtubule attachments during mitosis

  Varma, D.

  National Institute of General Medical Sciences

  12/10/19 → 11/30/24

  Project: Research project

• Collaborative Research: Dry Rifting In the Albertine-Rhino graben (DRIAR), Uganda

  van der Lee, S.

  National Science Foundation

  12/1/20 → 11/30/24

  Project: Research project

• Prot #AC-065B302: SELECT: SELExipag in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Group-Sequential, Adaptive, Phase 3 Study with Open-Label

  Cuttica, M. J.

  Janssen Research & Development, LLC

  8/12/19 → 11/30/24

  Project: Research project

• Measuring Electrical Activity from the Human Brain to Predict Memory Formation and Behavior Across the Lifespan

  Johnson, L.

  National Institute of Neurological Disorders and Stroke

  12/15/21 → 11/30/24

  Project: Research project

• Adaption, Implementation and Testing of a Telehealth Diabetes Discharge Intervention to Improve Transitions of Care

  Wallia, A., Ackermann, R. T., Ankenman, B. E., Bailey, S. C., Gatchell, D. W., Rees Lewis, D. G. & Welty, L. J.

  National Institute of Diabetes and Digestive and Kidney Diseases

  12/1/21 → 11/30/24

  Project: Research project

• Molecular mechanisms controlling kinetochore-microtubule attachments during mitosis

  Varma, D.

  National Institute of General Medical Sciences

  12/10/19 → 11/30/24

  Project: Research project

• Development of spectroscopic Single-Molecule Localization Microscopy

  Sun, C., Zhang, H. F. & Bao, X.

  National Institute of General Medical Sciences

  12/1/20 → 11/30/24

  Project: Research project

• Mechanism of Herpes Simplex Virus (HSV) Induced Membrane Fusion

  Longnecker, R. M.

  National Institute of Allergy and Infectious Diseases

  12/1/19 → 11/30/24

  Project: Research project

• Evaluating a mobile application to reduce distress in breast cancer survivors using an adaptive design

  Mohr, D. C.

  University of Virginia, National Cancer Institute

  12/1/20 → 11/30/24

  Project: Research project

• Fine-Tuned Search for Kilonova Emission in a Short Gamma-Ray Burst: Implications for the Progenitors, GW Sources, and r-Process Nucleosynthesis

  Fong, W.

  Space Telescope Science Institute, National Aeronautics and Space Administration

  12/1/21 → 11/30/24

  Project: Research project

• Mathematical Modeling to inform Urban Malaria microstratification

  Ozodiegwu, I. D.

  Bill & Melinda Gates Foundation

  12/6/21 → 11/30/24

  Project: Research project

• Prot#AG10-304: An Open-Label Extension and Safety Monitoring Study of Acoramidis (AG10) in Participants with Symptomatic Transthyretin Amyloid Cardiomyopathy Who Completed the Phase 3 ATTRibute-CM Trial (AG10-301)

  Shah, S. J.

  Pharmaceutical Research Associates, Inc., Eidos Therapeutics, Inc.

  12/1/21 → 12/1/24

  Project: Research project

• Prot# ISIS 396443-CS11: An Open-label Extension Study for Patients with Spinal Muscular Atrophy who Previously Participated in Investigational Studies of ISIS 396443

  Krosschell, K.

  Ann & Robert H. Lurie Children's Hospital of Chicago, Isis Pharmaceuticals, Inc.

  12/1/15 → 12/1/24

  Project: Research project

• Prot #M15-954: A Randomized, Double-Blind, Phase 3 Study Evaluating the Safety and Efficacy of Venetoclax in Combination with Azacitidine in Patients Newly Diagnosed with Higher-Risk Myelodysplastic Syndrome (Higher-Risk MDS)

  Frankfurt, O.

  AbbVie Inc.

  12/1/20 → 12/1/24

  Project: Research project

• Prot #SARC041: Phase 3 Randomized Double-Blind Study of Abemaciclib versus Placebo in Patients with Advanced Dedifferentiated Liposarcoma

  Pollack, S. M.

  SARC, Lilly USA, LLC

  12/2/21 → 12/2/24

  Project: Research project

• Prot#EX9536-4665: Effect of Semaglutide 2.4 mg Once Weekly on Function and Symptoms in Subjects with Obesity-Related Heart Failure with Preserved Ejection Fraction

  Patel, R. B.

  Novo Nordisk Inc.

  12/2/21 → 12/2/24

  Project: Research project

• Master Clinical Trial Agreement - HEALEY ALS Platform Trial

  Ajroud-Driss, S.

  Massachusetts General Hospital

  12/5/19 → 12/4/24

  Project: Research project

• Study# 2013-05C: Edwards EVOQUE Eos Mitral Valve Replacement: Investigation of Safety and Performance after Mitral Valve Replacement with Transcatheter Device

  Davidson, C. J.

  Edwards Lifesciences LLC

  12/6/16 → 12/6/24

  Project: Research project

• Define AFIB

  Patil, K. D.

  Medtronic, Inc.

  12/8/21 → 12/8/24

  Project: Research project

• Prot #VX20-121-102: A Phase 3, Randomized, Double-blind, Controlled Study Evaluating the Efficacy and Safety of VX-121 Combination Therapy in Subjects With Cystic Fibrosis Who Are Heterozygous for F508del and a Minimal Function Mutation (F/MF)

  Jain, M.

  Vertex Pharmaceuticals Incorporated

  12/13/21 → 12/13/24

  Project: Research project